171 related articles for article (PubMed ID: 12296969)
1. Effect of TT virus co-infection on interferon response in chronic hepatitis C patients.
Kawanaka M; Niiyama G; Mahmood S; Ifukube S; Yoshida N; Onishi H; Hanano S; Ito T; Yamada G
Liver; 2002 Aug; 22(4):351-5. PubMed ID: 12296969
[TBL] [Abstract][Full Text] [Related]
2. Clinical impact of genotype 1 TT virus infection in patients with chronic hepatitis C and response of TT virus to alpha-interferon.
Nishizawa Y; Tanaka E; Orii K; Rokuhara A; Ichijo T; Yoshizawa K; Kiyosawa K
J Gastroenterol Hepatol; 2000 Nov; 15(11):1292-7. PubMed ID: 11129224
[TBL] [Abstract][Full Text] [Related]
3. [Viral co-infections in hepatitis C: HBV, HBV-C/HGV and TTV studies].
Pár A; Takács M; Brojnás J; Berencsi G; Paál M; Horányi M; Miseta A; Hegedüs G; Mózsik G; Hunyady B
Orv Hetil; 2004 May; 145(19):987-92. PubMed ID: 15181733
[TBL] [Abstract][Full Text] [Related]
4. Clinical implications of TT virus superinfection in patients with chronic hepatitis C.
Watanabe H; Saito T; Kawamata O; Shao L; Aoki M; Terui Y; Mitsuhashi H; Matsuo T; Takeda Y; Saito K; Togashi H; Shinzawa H; Takahashi T
Am J Gastroenterol; 2000 Jul; 95(7):1776-80. PubMed ID: 10925984
[TBL] [Abstract][Full Text] [Related]
5. The response of hepatitis C virus and TT virus to high dose and long duration interferon-alpha therapy in naïve chronic hepatitis C patients.
Dai CY; Yu ML; Chuang WL; Hou NJ; Hou C; Chen SC; Lin ZY; Hsieh MY; Wang LY; Chang WY
Antiviral Res; 2002 Jan; 53(1):9-18. PubMed ID: 11684312
[TBL] [Abstract][Full Text] [Related]
6. Influence of TT virus co-infection on IFN-beta therapy in patients with chronic hepatitis C.
Yamada T; Naitou H; Morita T
Kansenshogaku Zasshi; 2002 Sep; 76(9):747-53. PubMed ID: 12391678
[TBL] [Abstract][Full Text] [Related]
7. Response of TT virus to IFN plus ribavirin treatment in patients with chronic hepatitis C.
Moreno J; Moraleda G; Barcena R; Mateos M; del Campo S
World J Gastroenterol; 2004 Jan; 10(1):143-6. PubMed ID: 14695786
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of TT virus in chronic hepatitis C.
Meng XW; Komatsu M; Goto T; Nakane K; Ohshima S; Yoneyama K; Lin JG; Watanabe S
J Gastroenterol Hepatol; 2001 Feb; 16(2):202-8. PubMed ID: 11207902
[TBL] [Abstract][Full Text] [Related]
9. Influence of transfusion-transmitted virus infection on the clinical features and response to interferon therapy in Japanese patients with chronic hepatitis C.
Hagiwara H; Hayashi N; Mita E; Oshita M; Kobayashi I; Iio S; Hiramatsu N; Sasaki Y; Kasahara A; Kakinuma K; Yamauchi T; Fusamoto H
J Viral Hepat; 1999 Nov; 6(6):463-9. PubMed ID: 10607265
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology and clinical significance of chronic hepatitis-related viruses infection in hemodialysis patients from Taiwan.
Dai CY; Yu ML; Chuang WL; Sung MH; Lin ZY; Chen SC; Hsieh MY; Wang LY; Tsai JF; Chang WY
Nephron; 2002 Feb; 90(2):148-53. PubMed ID: 11818698
[TBL] [Abstract][Full Text] [Related]
11. Relationships between TT virus infection and hepatitis C virus response to interferon therapy in doubly infected patients.
Maggi F; Fornai C; Tempestini E; Andreoli E; Lanini L; Vatteroni ML; Pistello M; Marchi S; Antonelli G; Bendinelli M
J Biol Regul Homeost Agents; 2003; 17(2):176-82. PubMed ID: 14518719
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of TT virus and GB virus C/hepatitis G virus infection in individuals with raised liver enzymes but without HBV or HCV infection in Taiwan.
Dai CY; Yu ML; Chang WY; Tseng CH; Hou C; Lin ZY; Chen SC; Hsieh MY; Wang LY; Tsai JF; Chuang WL
Epidemiol Infect; 2002 Oct; 129(2):307-13. PubMed ID: 12403107
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of SEN-virus on interferon response in chronic hepatitis C patients.
Lin JG; Goto T; Nakane K; Miura K; Mikami K; Ohshima S; Yoneyama K; Watanabe S
J Gastroenterol Hepatol; 2003 Oct; 18(10):1144-9. PubMed ID: 12974900
[TBL] [Abstract][Full Text] [Related]
14. TT virus infection in patients with chronic hepatitis C virus infection--effect of primers, prevalence, and clinical significance. Hepatitis Interventional Therapy Group.
Mizokami M; Albrecht JK; Kato T; Orito E; Lai VC; Goodman Z; Hong Z; Lau JY
J Hepatol; 2000 Feb; 32(2):339-43. PubMed ID: 10707876
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcome of frequent exposure to Torque Teno virus (TTV) through blood transfusion in thalassemia patients with or without hepatitis C virus (HCV) infection.
Hu YW; Al-Moslih MI; Al Ali MT; Uzicanin S; Perkins H; Yi QL; Rahimi Khameneh S; Wu J; Brown EG
J Med Virol; 2008 Feb; 80(2):365-71. PubMed ID: 18098140
[TBL] [Abstract][Full Text] [Related]
16. The epidemiology of TT virus (TTV) infection in a hepatitis C and B virus hyperendemic area of southern Taiwan.
Dai CY; Yu ML; Chuang WL; Lu SN; Wang JH; Huang JF; Hou C; Chen SC; Lin ZY; Hsieh MY; Wang LY; Tsai JF; Chang WY
Kaohsiung J Med Sci; 2000 Oct; 16(10):500-9. PubMed ID: 11272796
[TBL] [Abstract][Full Text] [Related]
17. TT virus infection in patients with chronic hepatitis B or C: influence on clinical, histological and virological features.
Kao JH; Chen W; Chen PJ; Lai MY; Chen DS
J Med Virol; 2000 Apr; 60(4):387-92. PubMed ID: 10686020
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of occult hepatitis B virus infection and Torque teno virus infection and their association with hepatocellular carcinoma in chronic hepatitis C patients.
Rosa AS; Araujo OC; Savassi-Ribas F; Fernandes CA; Coelho HS; Niel C; Villela-Nogueira CA; Araujo NM
Virus Res; 2017 Oct; 242():166-172. PubMed ID: 28966070
[TBL] [Abstract][Full Text] [Related]
19. TT virus infection in Italy: prevalence and genotypes in healthy subjects, viral liver diseases and asymptomatic infections by parenterally transmitted viruses.
Masia G; Ingianni A; Demelia L; Faa G; Manconi PE; Pilleri G; Ciancio A; Rizzetto M; Coppola RC
J Viral Hepat; 2001 Sep; 8(5):384-90. PubMed ID: 11555197
[TBL] [Abstract][Full Text] [Related]
20. Co-infections with hepatitis G and TT virus in patients with chronic hepatitis C in Hungary.
Pár A; Takács M; Brojnás J; Berencsi G; Paál M; Horányi M; Miseta A; Hegedüs G; Mózsik G; Hunyady B
Acta Microbiol Immunol Hung; 2004; 51(4):437-47. PubMed ID: 15704332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
